ENGN Q1 2025 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena

ENGNenGene Holdings Inc.

$359M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$102,000

Operating Income

-$27M

Net Income

-$25M

EPS (Diluted)

$-0.48

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$286M

Total Liabilities

$36M

Stockholders' Equity

$250M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$102,000	-$80,000	-27.5%
Operating Income	-$27M	-$11M	-147.0%
Net Income	-$25M	-$11M	-129.8%